Barclays’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-976
Closed -$12K 4169
2021
Q3
$12K Sell
976
-247
-20% -$3.34K ﹤0.01% 4489
2021
Q2
$19K Sell
1,223
-4,304
-78% -$72.4K ﹤0.01% 4505
2021
Q1
$133K Buy
5,527
+3,393
+159% +$95.3K ﹤0.01% 3886
2020
Q4
$63K Sell
2,134
-843
-28% -$18.3K ﹤0.01% 4317
2020
Q3
$46K Buy
2,977
+14
+0.5% +$264 ﹤0.01% 4646
2020
Q2
$73K Buy
2,963
+1,298
+78% +$28.2K ﹤0.01% 4719
2020
Q1
$34K Sell
1,665
-3,378
-67% -$80.6K ﹤0.01% 5426
2019
Q4
$156K Buy
5,043
+2,557
+103% +$82.9K ﹤0.01% 5208
2019
Q3
$83K Sell
2,486
-765
-24% -$24.6K ﹤0.01% 5611
2019
Q2
$104K Buy
3,251
+1,841
+131% +$58.8K ﹤0.01% 5660
2019
Q1
$40K Buy
+1,410
New +$49.1K ﹤0.01% 6024
2018
Q4
Sell
-2,360
Closed -$110K 6961
2018
Q3
$110K Buy
2,360
+1,983
+526% +$138K ﹤0.01% 5459
2018
Q2
$31K Sell
377
-4,243
-92% -$286K ﹤0.01% 5940
2018
Q1
$193K Sell
4,620
-2,052
-31% -$76.6K ﹤0.01% 4858
2017
Q4
$217K Buy
+6,672
New +$181K ﹤0.01% 4613

Other funds holding CASI